Inloggad som:

ROS-studien

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.

ROS-studien
An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer-sponsored studies
An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer-sponsored studies
PLACEHOLDER
Roll-over studie för patieter inkluderade i Bayer-studier med darolutamide för fortsatt behandling
Mer information om studien för vårdgivare
Prostatacancer
Behandling
Fas 3
Palliativ
Företag

Studien ändrades senast av: studysonia (2022-10-03)

Tillbaka till listan